Global Bone Morphogenetic Protein (BMP) 2 Market Analysis and Forecast 2024-2030

Global Bone Morphogenetic Protein (BMP) 2 Market Analysis and Forecast 2024-2030


Summary

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

According to APO Research, The global Bone Morphogenetic Protein (BMP) 2 market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Bone Morphogenetic Protein (BMP) 2 include Medtronic, Jiuyuan Gene Engineering and Cellumed, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Bone Morphogenetic Protein (BMP) 2, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Bone Morphogenetic Protein (BMP) 2, also provides the revenue of main regions and countries. Of the upcoming market potential for Bone Morphogenetic Protein (BMP) 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bone Morphogenetic Protein (BMP) 2 revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Bone Morphogenetic Protein (BMP) 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Bone Morphogenetic Protein (BMP) 2 revenue, projected growth trends, production technology, application and end-user industry.

Bone Morphogenetic Protein (BMP) 2 segment by Company

Medtronic
Jiuyuan Gene Engineering
Cellumed
Bone Morphogenetic Protein (BMP) 2 segment by Type

Sponge
Gel
Bone Morphogenetic Protein (BMP) 2 segment by Application

Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive Surgery
Bone Morphogenetic Protein (BMP) 2 segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bone Morphogenetic Protein (BMP) 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bone Morphogenetic Protein (BMP) 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bone Morphogenetic Protein (BMP) 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Bone Morphogenetic Protein (BMP) 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Bone Morphogenetic Protein (BMP) 2 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bone Morphogenetic Protein (BMP) 2 revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Bone Morphogenetic Protein (BMP) 2 Market by Type
1.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Sponge
1.2.3 Gel
1.3 Bone Morphogenetic Protein (BMP) 2 Market by Application
1.3.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Spinal Fusion
1.3.3 Trauma Surgery
1.3.4 Oral Maxillofacial Surgery
1.3.5 Reconstructive Surgery
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Bone Morphogenetic Protein (BMP) 2 Market Dynamics
2.1 Bone Morphogenetic Protein (BMP) 2 Industry Trends
2.2 Bone Morphogenetic Protein (BMP) 2 Industry Drivers
2.3 Bone Morphogenetic Protein (BMP) 2 Industry Opportunities and Challenges
2.4 Bone Morphogenetic Protein (BMP) 2 Industry Restraints
3 Global Growth Perspective
3.1 Global Bone Morphogenetic Protein (BMP) 2 Market Perspective (2019-2030)
3.2 Global Bone Morphogenetic Protein (BMP) 2 Growth Trends by Region
3.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2019-2024)
3.2.3 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Players
4.1.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Players (2019-2024)
4.1.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Players (2019-2024)
4.1.3 Global Bone Morphogenetic Protein (BMP) 2 Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Bone Morphogenetic Protein (BMP) 2 Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Bone Morphogenetic Protein (BMP) 2 Key Players Headquarters & Area Served
4.4 Global Bone Morphogenetic Protein (BMP) 2 Players, Product Type & Application
4.5 Global Bone Morphogenetic Protein (BMP) 2 Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Bone Morphogenetic Protein (BMP) 2 Market CR5 and HHI
4.6.2 Global Top 5 and 10 Bone Morphogenetic Protein (BMP) 2 Players Market Share by Revenue in 2023
4.6.3 2023 Bone Morphogenetic Protein (BMP) 2 Tier 1, Tier 2, and Tier 3
5 Bone Morphogenetic Protein (BMP) 2 Market Size by Type
5.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2030)
5.3 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Type (2019-2030)
6 Bone Morphogenetic Protein (BMP) 2 Market Size by Application
6.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2030)
6.3 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Comapny Information
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Bone Morphogenetic Protein (BMP) 2 Product Portfolio
7.1.5 Medtronic Recent Developments
7.2 Jiuyuan Gene Engineering
7.2.1 Jiuyuan Gene Engineering Comapny Information
7.2.2 Jiuyuan Gene Engineering Business Overview
7.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2019-2024)
7.2.4 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product Portfolio
7.2.5 Jiuyuan Gene Engineering Recent Developments
7.3 Cellumed
7.3.1 Cellumed Comapny Information
7.3.2 Cellumed Business Overview
7.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2019-2024)
7.3.4 Cellumed Bone Morphogenetic Protein (BMP) 2 Product Portfolio
7.3.5 Cellumed Recent Developments
8 North America
8.1 North America Bone Morphogenetic Protein (BMP) 2 Revenue (2019-2030)
8.2 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2030)
8.2.1 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2024)
8.2.2 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2025-2030)
8.3 North America Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2019-2030)
8.4 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2030)
8.4.1 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2024)
8.4.2 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2025-2030)
8.5 North America Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2019-2030)
8.6 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country
8.6.1 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2019-2024)
8.6.3 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Bone Morphogenetic Protein (BMP) 2 Revenue (2019-2030)
9.2 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2030)
9.2.1 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2024)
9.2.2 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2025-2030)
9.3 Europe Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2019-2030)
9.4 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2030)
9.4.1 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2024)
9.4.2 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2025-2030)
9.5 Europe Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2019-2030)
9.6 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country
9.6.1 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2019-2024)
9.6.3 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Bone Morphogenetic Protein (BMP) 2 Revenue (2019-2030)
10.2 China Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2030)
10.2.1 China Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2024)
10.2.2 China Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2025-2030)
10.3 China Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2019-2030)
10.4 China Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2030)
10.4.1 China Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2024)
10.4.2 China Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2025-2030)
10.5 China Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Bone Morphogenetic Protein (BMP) 2 Revenue (2019-2030)
11.2 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2030)
11.2.1 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2024)
11.2.2 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2025-2030)
11.3 Asia Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2019-2030)
11.4 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2030)
11.4.1 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2024)
11.4.2 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2025-2030)
11.5 Asia Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2019-2030)
11.6 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Country
11.6.1 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2019-2024)
11.6.3 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue (2019-2030)
12.2 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2030)
12.2.1 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2019-2024)
12.2.2 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2025-2030)
12.3 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2019-2030)
12.4 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2030)
12.4.1 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2019-2024)
12.4.2 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2025-2030)
12.5 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2019-2030)
12.6 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Country
12.6.1 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2019-2024)
12.6.3 MEALA Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings